|
|
In Vitro & In Vivo Diagnostic Substances Industry
Efficiency Information & Trends
Industry: In Vitro & In Vivo Diagnostic Substances ▼
|
Category:
|
|
|
In Vitro & In Vivo Diagnostic Substances ▼
|
In Vitro & In Vivo Diagnostic Substances Industry |
1 Q |
4 Q |
3 Q |
2 Q |
1 Q |
|
Q1 2025 |
Q4 2024 |
Q3 2024 |
Q2 2024 |
Q1 2024 |
Revenue/Employee (TTM) $ |
498,191 |
498,430 |
495,039 |
489,317 |
481,778 |
Sales/Employee Ranking |
# 42 |
# 16 |
# 73 |
# 2 |
# 48 |
Net Income/Employee (TTM) $ |
- |
- |
- |
- |
- |
Net Income/Employee
Ranking |
# 102 |
# 36 |
# 23 |
# 97 |
# 103 |
Receivable Turnover Ratio (TTM) |
6.99 |
7.04 |
7.08 |
7.18 |
7.36 |
Receivable Turnover Ranking |
# 60 |
# 29 |
# 46 |
# 51 |
# 59 |
Inventory Turnover Ratio (TTM) Sales |
7.98 |
7.94 |
7.92 |
8.05 |
8.04 |
Inventory Turnover (Sales)
Ranking |
# 54 |
# 18 |
# 40 |
# 63 |
# 57 |
Inventory Turnover Ratio (TTM) COS |
3.4 |
3.42 |
3.39 |
3.46 |
3.47 |
Inventory Turnover (COS)
Ranking |
# 77 |
# 23 |
# 61 |
# 69 |
# 80 |
Asset Turnover Ratio (TTM) |
0.52 |
0.54 |
0.52 |
0.51 |
0.5 |
Asset Turnover Ranking
|
# 70 |
# 36 |
# 19 |
# 74 |
# 70 |
Revenue per Employee Comment |
Revenue per employee fell on trailing twelve months basis ending 1 Q 2025 for the In Vitro & In Vivo Diagnostic Substances Industry to 498,191 $ compared to twelve month period ending 4 Q 2025below In Vitro & In Vivo Diagnostic Substances Industry average.
Within Healthcare sector 2 other industries have achieved higher Revenue per employee. Revenue per employee total ranking has deteriorated compared to the previous quarter from 16 to 42.
|
Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.
Revenue per Employee Statistics as of 1 Q 2025 |
High |
Average |
Low |
$ 594,152 |
$ 507,731 |
$ 468,443 |
3. quarter 2020 |
|
4. quarter 2023 |
Revenue per Employee Industry Ranking in the 1 Q 2025 |
Within: |
No. |
Sector |
# 3 |
S&P 500 |
# 42
|
In Vitro & In Vivo Diagnostic Substances Industry Net Income per Employee |
|
Net Income per Employee Statistics as of 1 Q 2025 |
High |
Average |
Low |
$ 97,893 |
$ 9,624 |
$ -85,643 |
1. quarter 2021 |
|
4. quarter 2024 |
Net Income per Employee Comment |
In Vitro & In Vivo Diagnostic Substances Industry recoded net loss per employee of -29,972 $.
Within Healthcare sector 6 other industries have achieved higher net income per employee. Net income per employee total ranking has deteriorated compared to prior quarter from 36 to 102.
|
Net Income per Employee Industry Ranking in the 1 Q 2025 |
Within: |
No. |
Sector |
# 7 |
S&P 500 |
# 102
|
|
In Vitro & In Vivo Diagnostic Substances Industry Receivable Turnover Ratio |
|
Receivable Turnover Ratio Comment |
In Vitro & In Vivo Diagnostic Substances Industry's Receivable turnover ratio sequentially increased to 6.99 in the 1 Q 2025, below In Vitro & In Vivo Diagnostic Substances Industry average.
Within Healthcare sector only one Industry has achieved higher receivable turnover ratio. Receivable turnover ratio total ranking has deteriorated compare to previous quarter from 29 to 60.
|
Receivable Turnover Ratio Statistics as of 1 Q 2025 |
High |
Average |
Low |
7.7 |
7.06 |
6.04 |
4. quarter 2023 |
|
1. quarter 2022 |
Receivable Turnover Ratio Industry Ranking in the 1 Q 2025 |
Within: |
No. |
Sector |
# 2 |
S&P 500 |
# 60
|
|
|
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Ratio (Sales) |
|
|
Inventory Turnover Ratio Statistics as of 1 Q 2025 |
High |
Average |
Low |
10.27 |
8.02 |
3.15 |
4. quarter 2020 |
|
4. quarter 2021 |
Inventory Turnover Ratio Comment |
In Vitro & In Vivo Diagnostic Substances Industry's inventory turnover ratio compared to previous quarter, increased to 7.98 in the 1 Q 2025, below In Vitro & In Vivo Diagnostic Substances Industry average.
Within Healthcare sector 3 other industries have achieved higher Inventory Turnover Ratio. Inventory Turnover Ratio total ranking has deteriorated compared to quarter before from 18 to 54.
|
Inventory Turnover Ratio Industry Ranking in the 1 Q 2025 |
Within: |
No. |
Sector |
# 3 |
S&P 500 |
# 77
|
|
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Ratio COS |
|
|
Inventory Turnover Ratio COS Statistics as of 1 Q 2025 |
High |
Average |
Low |
5.52 |
3.32 |
0 |
4. quarter 2020 |
|
4. quarter 2021 |
Inventory Turnover Ratio COS Comment |
Due to inventory build up, inventory turnover ratio sequentially decreased to 3.4 in the 1 Q 2025and remained above Industry average.
Within Healthcare sector 2 other industries have achieved higher Inventory Turnover COS Ratio. Inventory Turnover COS Ratio total ranking has deteriorated compared to prior quarter from 23 to 77.
|
Inventory Turnover Ratio Industry COS Ranking in the 1 Q 2025 |
Within: |
No. |
Sector |
# 3 |
S&P 500 |
# 77
|
|
In Vitro & In Vivo Diagnostic Substances Industry Asset Turnover Ratio |
|
Asset Turnover Ratio Comment |
With revenue increase of 4.02 % in the 1 Q 2025, from same quarter a year ago, In Vitro & In Vivo Diagnostic Substances Industry's asset turnover ratio increased to 0.52 , lower than In Vitro & In Vivo Diagnostic Substances Industry average.
Within Healthcare sector 3 other industries have achieved higher asset turnover ratio. Asset turnover ratio total ranking has deteriorated compare to previous quarter from 36 to 70.
|
Asset Turnover Ratio Statistics as of 1 Q 2025 |
High |
Average |
Low |
0.73 |
0.47 |
0.06 |
3. quarter 2020 |
|
4. quarter 2021 |
Asset Turnover Ratio Industry Ranking in the 1 Q 2025 |
Within: |
No. |
Sector |
# 4 |
S&P 500 |
# 70
|
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com